发明名称 METHODS AND COMPOSITION FOR IDENTIFYING THERAPEUTIC AGENTS OF ATHEROSCLEROTIC PLAQUE LESIONS
摘要 The present invention relates to a method for monitoring the growth, erosion, rupture or stability of an atherosclerotic plaque comprising the analysis of the differential expression of at least one gene coding a protein chosen among Stearoyl CoA deasturase, Aldose reductase and aldehyde reductase, Sphingomyelinase, Acid ceramidase, Ceramide glucosyl transferase, Sphingosin phosphate liase, Thymosine beta 4, Aldehyde dehydrogenase, ATPase Ca++ binding protein and CD163.
申请公布号 AU2003296853(A1) 申请公布日期 2004.07.14
申请号 AU20030296853 申请日期 2003.12.19
申请人 CLINIGENETICS 发明人 GERARD MARGUERIE;NORA BENHABILES
分类号 A61K45/06;C12Q1/68;(IPC1-7):C12Q1/68 主分类号 A61K45/06
代理机构 代理人
主权项
地址